Skip to main content

Advertisement

Table 1 The clinical characteristics of 136 patients with advanced gastric cancer

From: Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer

Characteristic Total n = 136 (%) NLR PLR
Mean ± SEM P value Mean ± SEM P value
Gender    0.876   0.115
 Male 82 (60.3%) 3.36 ± 0.30   191.66 ± 11.84  
 Female 54 (39.7%) 3.43 ± 0.37   222.64 ± 16.00  
Age    0.446   0.966
 ≤55 years 74 (54.4%) 3.55 ± 0.37   204.34 ± 12.45  
 >55 years 62 (45.6%) 3.20 ± 0.24   203.51 ± 15.06  
Differentiation    0.144   0.169
 Poor 90 (66.2%) 3.59 ± 0.32   213.43 ± 10.70  
 Moderate/Well 46 (33.8%) 2.99 ± 0.25   185.44 ± 19.07  
Chemotherapy regimen    0.158   0.964
 FOLFOX 40 (29.4%) 3.77 ± 0.52   209.31 ± 16.29  
 CapeOX 26 (19.1%) 3.94 ± 0.70   200.37 ± 26.76  
 TP 21 (15.4%) 3.58 ± 0.42   210.15 ± 22.98  
 Others 49 (36.1%) 2.71 ± 0.22   198.85 ± 15.84